Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Y M, Woo"'
Autor:
Maxwell C. Y. Choi, Tiffany H. P. Law, Sirong Chen, William S. K. Cheung, Carmen Yim, Oliver K. S. Ng, Lisa W. C. Au, Vincent C. T. Mok, Peter Y. M. Woo
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Cases of iatrogenic cerebral amyloid angiopathy (CAA) have been increasingly reported recently, particularly those associated with neurosurgery. Preclinical studies have shown taxifolin to be promising for treating CAA. We describe a young 42-year-ol
Externí odkaz:
https://doaj.org/article/42603084166b434c9baa120dbd255e40
Publikováno v:
Journal of Neuroanaesthesiology and Critical Care, Vol 09, Iss 02, Pp 135-138 (2022)
Externí odkaz:
https://doaj.org/article/fdf651236a814d0ab4ec6c3db0cd06c5
Autor:
Peter Y. M. Woo, Ben C. F. Ng, June H. M. Wong, Oliver K. S. Ng, Timothy S. K. Chan, Ngai-Fung Kwok, Kwong-Yau Chan
Publikováno v:
Chinese Neurosurgical Journal, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background IgG4-related hypertrophic pachymeningitis is a relative newly recognized and rare manifestation of IgG4-related disease, an immune-mediated fibroinflammatory tumefactive disorder. Fewer than 80 patients have been reported in the l
Externí odkaz:
https://doaj.org/article/e8daebe8762545df8e14f5367b9e96c5
Autor:
Peter Y. M. Woo, Joanna W. K. Ho, Natalie M. W. Ko, Ronald P. T. Li, Leo Jian, Alberto C. H. Chu, Marco C. L. Kwan, Yung Chan, Alain K. S. Wong, Hoi-Tung Wong, Kwong-Yau Chan, John C. K. Kwok
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-14 (2020)
Asbtract Background There are limited neuroprotective treatment options for patients with aneurysmal subarachnoid hemorrhage (SAH). Cerebrolysin, a brain-specific proposed pleiotropic neuroprotective agent, has been suggested to improve global functi
Externí odkaz:
https://doaj.org/article/fc6dbe1447ab4d6ba620c1b23a29201b
Autor:
Peter Y. M. Woo, Yi Li, Anna H. Y. Chan, Stephanie C. P. Ng, Herbert H. F. Loong, Danny T. M. Chan, George K. C. Wong, Wai-Sang Poon
Publikováno v:
Glioma, Vol 2, Iss 2, Pp 68-82 (2019)
Temozolomide (TMZ), an oral alkylating agent, is a cornerstone of standard-of-care multimodality therapy for glioblastoma. In spite of significant efforts to treat this disease, the tumor carries a poor prognosis and is considered incurable largely d
Externí odkaz:
https://doaj.org/article/3652e18040d640ffbf90f719b93ec390
Autor:
Amelia Y. M. Woo, Miguel A. Aguilar Ramos, Rohan Narayan, Khyle C. Richards-Corke, Michelle L. Wang, Walter J. Sandoval-Espinola, Emily P. Balskus
Publikováno v:
Nature Reviews Chemistry. 7:319-339
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study
Autor:
Peter Y. M. Woo, Tiffany H. P. Law, Kelsey K. Y. Lee, Joyce S. W. Chow, Lai-Fung Li, Sarah S. N. Lau, Tony K. T. Chan, Jason M. K. Ho, Michael W. Y. Lee, Danny T. M. Chan, Wai-Sang Poon
Publikováno v:
British Journal of Neurosurgery. :1-9
Publikováno v:
IEEE Transactions on Medical Imaging. 41:2953-2964
Autor:
Peter Y M Woo, Stephen Yau, Tai-Chung Lam, Jenny K S Pu, Lai-Fung Li, Louisa C Y Lui, Danny T M Chan, Herbert H F Loong, Michael W Y Lee, Rebecca Yeung, Carol C H Kwok, Siu-Kie Au, Tze-Ching Tan, Amanda N C Kan, Tony K T Chan, Calvin H K Mak, Henry K F Mak, Jason M K Ho, Ka-Man Cheung, Teresa P K Tse, Sarah S N Lau, Joyce S W Chow, Aya El-Helali, Ho-Keung Ng, Wai-Sang Poon
Publikováno v:
Neuro-Oncology Practice. 10:50-61
Background The aim of this study is to address the paucity of epidemiological data regarding the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma patients. Methods This was a population-level study of Hong Kong adult
Publikováno v:
Acta Neurochirurgica. 164:2057-2062